CORC

在结果中检索

CORC

浏览/检索结果: 共12条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study 期刊论文
2019, 卷号: 257, 期号: 3, 页码: 529-541
作者:  Li, Xiaoxin;  Dai, Hong;  Li, Xiaorong;  Han, Mei;  Li, Jun
收藏  |  浏览/下载：173/0  |  提交时间：2020/01/03
左归丸和巴氯芬联用对脑瘫鼠运动认知的影响 期刊论文
中国妇幼健康研究, 2015, 期号: [db:dc_citation_issue], 页码: 210-213
作者:  李玲;  焦银香;  张菡;  李静;  李红霞
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/02
A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC) 期刊论文
LUNG CANCER, 2014, 卷号: 86, 期号: 2
作者:  Hu, Xingsheng;  Han, Baohui;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC) 期刊论文
2014, 卷号: 86, 期号: 2, 页码: 207-212
作者:  Hu, Xingsheng;  Han, Baohui;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/13
Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15
作者:  Tan, Fenlai;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang;  Wang, Chang-Li
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15
作者:  Tan, Fenlai;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang;  Wang, Chang-Li
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial 期刊论文
The Lancet Oncology, 2013, 卷号: 14, 期号: 10, 页码: 953-961
作者:  Shi, Yuankai*;  Zhang, Li;  Liu, Xiaoqing;  Zhou, Caicun;  Zhang, Shucai
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/03
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial 期刊论文
LANCET ONCOLOGY, 2013, 卷号: 14, 期号: 10
作者:  Shi, Yuankai;  Zhang, Li;  Liu, Xiaoqing;  Zhou, Caicun;  Zhang, Li
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial 期刊论文
2013, 卷号: 14, 期号: 10, 页码: 953-961
作者:  Shi, Yuankai;  Zhang, Li;  Liu, Xiaoqing;  Zhou, Caicun;  Zhang, Shucai
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/13
Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20
作者:  Tan, Fenlai;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang;  Wang, Chang-Li
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace